Hematology/Oncology

Top Story

AMA urges Senate to reject Graham-Cassidy proposal

September 20, 2017

The AMA recently sent a letter to Senate Majority Leader Mitch McConnell and Minority Leader Charles Schumer strongly opposing the Graham-Cassidy legislation, emphasizing that the bill would result in the loss of health insurance coverage for millions of Americans while destabilizing health insurance markets.

“Similar to proposals that were considered in the Senate in July, we believe the Graham-Cassidy Amendment would result in millions of Americans losing their health insurance coverage, destabilize health insurance markets, and decrease access to affordable coverage and care,” James L. Madara, MD, CEO and executive vice president of AMA, wrote in the letter.

FDA News

FDA grants priority review to Trisenox for first-line acute promyelocytic leukemia

September 20, 2017
The FDA granted priority review to arsenic trioxide injection for use in combination with all-trans retinoic acid for induction of remission and consolidation in certain…
In the Journals Plus

HPV self-sampling could boost cervical cancer screening rates in transgender men

September 20, 2017
Alternative options for cervical cancer screening, such as self-sampling HPV tests, could increase screening uptake among transgender men, according to research results…
FDA News

FDA advisory committee split on opinion of adjuvant Sutent for renal cell carcinoma

September 19, 2017
The FDA’s Oncologic Drug Advisory Committee today voted 6-6 on whether the risk-benefit profile of sunitinib malate is acceptable for the adjuvant treatment of…
Meeting NewsPerspective

Nivolumab plus ipilimumab outperforms sunitinib in certain kidney cancers

September 19, 2017
MADRID — The immunotherapy combination of nivolumab plus ipilimumab improved objective response rate and prolonged PFS compared with sunitinib in intermediate- and…
More Headlines »
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video
Meeting News

VIDEO: Questions remain regarding use of gene-targeted therapy for lung cancer

June 23, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Polycythemia Vera: Aligning Real World Practices With Current Best Practices

This activity is supported by an independent educational grant from Incyte Corporation.

Ruben A. Mesa, MD, provides practical insights into treating polycythemia vera in this video series. In addition to…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement